Orris
analyse_media
The handwriting appears to read:
Somatopleuric
  • extraembryonic coelom
  • body cavity
  • skin and dermis
  • amnion and chorion
  • somatopleure
  • parietal mesoderm
A few words are faint, so this is a best-effort transcription.

Schizophrenia Etiology Causes Signs symptoms Classification Management

Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

schizophrenia AND treatment

Searching the Web

NICE schizophrenia adults guideline treatment overview

This is a broad topic. Here is the study map:
  1. Definition and core features
  2. Etiology and risk factors
  3. Causes and differential diagnosis of psychosis
  4. Signs and symptoms
  5. Classification
  6. Assessment and diagnosis
  7. Management, including medicines and psychosocial care
  8. Complications, prognosis, and relapse prevention
Schizophrenia is a chronic psychotic disorder involving disturbances in perception, thought, emotion, behavior, and functioning. Its cause is multifactorial, involving genetic susceptibility plus neurodevelopmental, biological, psychological, and social/environmental factors. Management combines antipsychotic medication, psychological and family interventions, rehabilitation, physical-health monitoring, and relapse prevention. Current guidance supports antipsychotic medication alongside psychological interventions, while clozapine is used for treatment-resistant illness after adequate trials of two antipsychotics, as summarized by NICE guidance. Recent systematic reviews continue to evaluate pharmacological and psychosocial approaches, including for treatment-resistant schizophrenia (PMIDs: 39951117, 38879276).
Asking for Preferences

Which section should I explain in detail first?

The handwriting appears to read:
Somatopleuric
  • extraembryonic coelom
  • body cavity
  • skin and dermis
  • amnion and chorion
  • somatopleure
  • parietal mesoderm
A few words are faint, so this is a best-effort transcription.This is a broad topic. Here is the study map:
  1. Definition and core features
  2. Etiology and risk factors
  3. Causes and differential diagnosis of psychosis
  4. Signs and symptoms
  5. Classification
  6. Assessment and diagnosis
  7. Management, including medicines and psychosocial care
  8. Complications, prognosis, and relapse prevention
Schizophrenia is a chronic psychotic disorder involving disturbances in perception, thought, emotion, behavior, and functioning. Its cause is multifactorial, involving genetic susceptibility plus neurodevelopmental, biological, psychological, and social/environmental factors. Management combines antipsychotic medication, psychological and family interventions, rehabilitation, physical-health monitoring, and relapse prevention. Current guidance supports antipsychotic medication alongside psychological interventions, while clozapine is used for treatment-resistant illness after adequate trials of two antipsychotics, as summarized by NICE guidance. Recent systematic reviews continue to evaluate pharmacological and psychosocial approaches, including for treatment-resistant schizophrenia (PMIDs: 39951117, 38879276).Which section would you like in detail first?
  1. Etiology and causes
  2. Signs and symptoms
  3. Classification
  4. Management
  5. Full exam-style note on all sections

Explain schizophrenia etiology and risk factors

Reading File
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

schizophrenia AND risk factors

Searching the Web

NIMH schizophrenia risk factors genetics environment cannabis pregnancy complications

Reading File
Reading File
Finding Sources
Finding Sources

Schizophrenia: Etiology and Risk Factors

Etiology

The exact cause of schizophrenia is not known. It is best understood as a multifactorial neurodevelopmental disorder: a person with genetic vulnerability may develop illness when environmental and developmental exposures affect brain maturation and neural circuits.
Simple model:
Genetic susceptibility + abnormal brain development + environmental stressors/exposures = increased risk of schizophrenia
No single gene, parenting style, life event, or substance alone explains every case. Risk factors increase probability but do not mean that a person will definitely develop schizophrenia.

1. Genetic factors

Schizophrenia has a strong genetic contribution.
  • It is polygenic: many common genetic variants each contribute a small effect.
  • Rare copy-number variations and new mutations may contribute more strongly in some people.
  • Family, twin, and adoption studies show that the risk is higher in biological relatives.
  • Textbook estimates place heritability at about 79%, although heritability is a population statistic and does not mean 79% of an individual’s illness is caused by genes.
  • Concordance is higher in identical than non-identical twins, but it is not 100%, proving that genes alone are insufficient.
Kaplan & Sadock describes schizophrenia as highly heritable and polygenic, with both common low-effect variants and rarer high-effect variants contributing to risk. Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, p. 4545.

2. Neurodevelopmental factors

The brain develops from fetal life through adolescence. Disruption during sensitive periods may lead to altered brain circuitry, which may become clinically apparent in late adolescence or early adulthood.
Possible abnormalities involve:
  • Synapse formation and pruning
  • Neuronal migration and connectivity
  • Cortical maturation
  • Excitatory-inhibitory balance, particularly glutamate and GABA circuits
  • Prefrontal and hippocampal network function
Thus, schizophrenia is not usually considered a disorder that suddenly begins at the first psychotic episode. Rather, the vulnerability may begin much earlier, while the overt illness typically appears later.

3. Neurochemical mechanisms

These mechanisms help explain symptoms and treatment response, but they are not complete explanations of the cause.
  • Dopamine dysregulation: Excess dopamine activity in mesolimbic pathways is linked to positive symptoms such as hallucinations and delusions. Reduced dopamine activity in some cortical pathways may contribute to negative and cognitive symptoms.
  • Glutamate/NMDA receptor hypofunction: Reduced NMDA glutamate receptor function may disturb cortical circuits and indirectly alter dopamine signaling.
  • GABA dysfunction: Impaired inhibitory GABA interneuron function may affect cognition and coordinated neural activity.
  • Serotonin and other systems: These can modulate dopamine and glutamate pathways.
These biological abnormalities likely arise through interactions between genes, developmental events, and environmental exposures, rather than being a single primary defect.

Risk Factors

A. Family history and genetic vulnerability

Risk is increased in people with:
  • A first-degree relative with schizophrenia or another psychotic disorder
  • A family history of schizophrenia-spectrum disorders
  • A high polygenic genetic liability
This is a risk, not a diagnosis. Most relatives of affected people do not develop schizophrenia.

B. Pregnancy, fetal, and perinatal factors

Factors associated with increased risk include:
  • Maternal infections during pregnancy
  • Maternal malnutrition or severe nutritional deficiency
  • Significant maternal stress
  • Obstetric complications
  • Fetal hypoxia or birth asphyxia
  • Prematurity or low birth weight in some studies
  • Birth complications affecting early brain development
These associations support the neurodevelopmental model. They do not prove that any one complication directly causes schizophrenia in an individual person.

C. Childhood and adolescent adversity

Risk is associated with:
  • Childhood trauma, abuse, neglect, or severe adversity
  • Bullying and social exclusion
  • Chronic psychosocial stress
  • Early parental loss or highly adverse family environments
  • Migration, discrimination, or social defeat in some populations
  • Urban upbringing or urban living, possibly through social stress, pollution, infection exposure, or other correlated factors
These experiences may be particularly important in a genetically vulnerable person.

D. Cannabis and other substance exposure

Cannabis use, especially:
  • Early adolescent use
  • Frequent or heavy use
  • High-potency cannabis
  • Use in people with a family history or genetic vulnerability to psychosis
is associated with an increased risk of psychotic symptoms and schizophrenia-spectrum disorders. It may precipitate or bring forward psychosis in a vulnerable person. The direction of causality can be complex because some people may use cannabis before diagnosis due to early symptoms, but avoiding cannabis is a sensible risk-reduction measure for anyone vulnerable to psychosis.
Stimulants such as amphetamines and cocaine can also cause psychosis or worsen an underlying vulnerability. Substance-induced psychosis must be distinguished clinically from schizophrenia.

E. Social and demographic associations

Some epidemiological studies find increased risk associated with:
  • Growing up in densely urban environments
  • Migration and minority ethnic status in settings where social adversity or discrimination is common
  • Social isolation
  • Severe socioeconomic adversity
These are not explanations based on ethnicity or personal character. The probable relevant factors are social exclusion, discrimination, chronic stress, reduced support, and related environmental exposures.

F. Other possible associations

Research has also examined:
  • Advanced paternal age
  • Winter or spring birth
  • Vitamin D deficiency
  • Maternal immune activation and inflammation
  • Childhood infections
  • Sleep deprivation as a trigger for psychotic experiences in vulnerable people
The strength of evidence varies. These should be described as associations, not definite causes.

Gene-environment interaction

The most important concept is gene-environment interaction.
For example, a person may carry a genetic predisposition but never develop schizophrenia. Another person with the same predisposition may be more vulnerable if exposed to prenatal complications, severe childhood adversity, high-potency cannabis, or repeated stress.
Kaplan & Sadock notes that fetal and perinatal infections, nutritional deficiency, birth complications, and cannabis exposure are epidemiologically associated with neurodevelopmental abnormalities and schizophrenia. Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, p. 4545.
A recent review also maps environmental risks across different settings, but emphasizes that the evidence varies between exposures and populations (2025 systematic review, PMID 40910192).

Exam summary

Etiology of schizophrenia is multifactorial and neurodevelopmental. It results from an interaction of:
  1. Genetic factors: polygenic inheritance, family history, rare genetic variants.
  2. Neurodevelopmental factors: abnormal brain maturation, synaptic and circuit development.
  3. Neurochemical factors: dopamine dysregulation, glutamate/NMDA hypofunction, and GABA dysfunction.
  4. Environmental risk factors: prenatal infection/malnutrition, obstetric complications, childhood trauma, social adversity, urbanicity, migration-related stress, and cannabis exposure.
  5. Gene-environment interaction: environmental exposures have greater effects in genetically vulnerable individuals.
This is a shared conversation. Sign in to Orris to start your own chat.